<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>9(6)</volume><submitter>Yang X</submitter><pubmed_abstract>The aim of this study is to explore the active components and potential molecular mechanism of action of &lt;i>Rubia cordifolia&lt;/i> L. against nasopharyngeal carcinoma (NPC). We used network pharmacology, molecular docking, and bioinformatics analysis to identify the active components and their role against NPC. The experimental verification was detected by MTT, AnnexinV-FITC/PI double fluorescence staining and Western blotting method. Network pharmacology identified that mollugin is one of the most effective components in&lt;i>Rubia cordifolia&lt;/i> L. Important NPC targets included HSP90AA1, CDK1, EGFR, PIK3CA, MAPK14, and CDK2. Molecular docking revealed considerable binding activity of mollugin with either of the 6 important NPC targets. Bioinformatics analysis showed that these 6 important ta</pubmed_abstract><journal>Heliyon</journal><pagination>e17078</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10361237</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Analysis of active components and molecular mechanism of action of &lt;i>Rubia cordifolia&lt;/i> L. in the treatment of nasopharyngeal carcinoma based on network pharmacology and experimental verification.</pubmed_title><pmcid>PMC10361237</pmcid><pubmed_authors>Yang X</pubmed_authors><pubmed_authors>Tang L</pubmed_authors><pubmed_authors>He Y</pubmed_authors><pubmed_authors>Lin T</pubmed_authors><pubmed_authors>Tao Y</pubmed_authors><pubmed_authors>Xu R</pubmed_authors><pubmed_authors>Luo W</pubmed_authors><pubmed_authors>Zhou F</pubmed_authors><pubmed_authors>He L</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of active components and molecular mechanism of action of &lt;i>Rubia cordifolia&lt;/i> L. in the treatment of nasopharyngeal carcinoma based on network pharmacology and experimental verification.</name><description>The aim of this study is to explore the active components and potential molecular mechanism of action of &lt;i>Rubia cordifolia&lt;/i> L. against nasopharyngeal carcinoma (NPC). We used network pharmacology, molecular docking, and bioinformatics analysis to identify the active components and their role against NPC. The experimental verification was detected by MTT, AnnexinV-FITC/PI double fluorescence staining and Western blotting method. Network pharmacology identified that mollugin is one of the most effective components in&lt;i>Rubia cordifolia&lt;/i> L. Important NPC targets included HSP90AA1, CDK1, EGFR, PIK3CA, MAPK14, and CDK2. Molecular docking revealed considerable binding activity of mollugin with either of the 6 important NPC targets. Bioinformatics analysis showed that these 6 important ta</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jun</publication><modification>2026-05-29T06:00:27.149Z</modification><creation>2024-11-05T20:23:31.445Z</creation></dates><accession>S-EPMC10361237</accession><cross_references><pubmed>37484327</pubmed><doi>10.1016/j.heliyon.2023.e17078</doi></cross_references></HashMap>